Pines Wealth Management’s Boston Scientific BSX Stock Holding History

Pines Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$496K	Sell	7,907 -530	-6%	-$42.4K	0.16%	129
2025 Q4	$804K	Sell	8,437 -398	-5%	-$39K	0.26%	94
2025 Q3	$863K	Sell	8,835 -224	-2%	-$23.2K	0.29%	88
2025 Q2	$945K	Buy	9,059 +674	+8%	+$68.2K	0.33%	77
2025 Q1	$760K	Sell	8,385 -28	-0.3%	-$2.82K	0.35%	73
2024 Q4	$798K	Buy	+8,413	New	+$741K	0.35%	71

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pines Wealth Management's BSX Position: Q1 2026 in Review

Pines Wealth Management reduced its Boston Scientific (BSX) stake by 6.3% in Q1 2026, selling an estimated $42.4K and leaving 7,907 shares worth $496K. The position accounts for 0.16% of the portfolio, ranked #129.

Pines Wealth Management first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $945K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Pines Wealth Management held 7,907 shares of Boston Scientific worth $496K as of Q1 2026.
Pines Wealth Management sold 530 Boston Scientific shares in Q1 2026, an estimated $42.4K.
Boston Scientific made up 0.16% of Pines Wealth Management's portfolio in Q1 2026, its #129 holding.
Pines Wealth Management first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
Pines Wealth Management's Boston Scientific position peaked at $945K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Pines Wealth Management's 13F filing for Q1 2026, filed 8 Apr 2026.